Xilio Therapeutics, Inc. (XLO)

CIK 1840233 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Xilio Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0001104659-26-096755
Aug 12, 202610-Q0001193125-26-345759
Aug 12, 20268-K0001193125-26-345753
Aug 12, 2026S-80001193125-26-345762
Jun 12, 202640001193125-26-269401
Jun 12, 20268-K0001193125-26-269358
Jun 12, 202640001193125-26-269400
Jun 12, 202640001193125-26-269395
Jun 12, 202640001193125-26-269398
Jun 12, 202640001193125-26-269396
Jun 12, 202640001193125-26-269399
Jun 12, 202640001193125-26-269397
May 29, 2026EFFECT9999999995-26-001811
May 27, 2026S-3/A0001193125-26-242204
May 15, 2026SCHEDULE 13G/A0001193125-26-226925
May 15, 2026SCHEDULE 13G/A0000919574-26-003488
May 15, 2026SCHEDULE 13G0000919574-26-003213
May 15, 2026SCHEDULE 13G0000947871-26-000552
May 12, 20268-K0001193125-26-218194
May 12, 2026S-30001193125-26-218212
May 12, 202610-Q0001193125-26-218200
Apr 28, 2026ARS0001193125-26-187691
Apr 28, 2026DEF 14A0001193125-26-187642
Apr 16, 202640001193125-26-159316
Apr 16, 202630001193125-26-159314